10X GENOMICS

Company Overview

10x Genomics is a life sciences technology company making advanced tools to explore, understand, and harness biology. The company’s product offering includes instruments, consumables, and software tailored for analyzing biological systems with high precision and scalability. It has collaborated with various fields such as chemistry, biology, hardware, and software, aiding researchers in oncology, immunology, and neuroscience breakthroughs. It functions as a single operating segment.

The company offers products through three platforms: Chromium, Visium, and Xenium. The Chromium platform segments biological samples into numerous partitions to facilitate high-throughput analysis. Each partition has a barcode for content identification, enabling pooling and sequencing. This platform delivers comprehensive solutions for single-cell tissue analysis, presenting multi-omic readouts such as gene expression, protein, and chromatin analysis. It supports various sample types and ensures exceptional performance characterized by high sensitivity and reproducibility. In contrast, the Visium platform specializes in spatial analysis of biological components utilizing DNA arrays, while the Xenium platform focuses on in situ analysis of RNA targets within tissue sections.

The company has a market presence in more than 50 countries, providing product offerings to end users primarily in academic, government, biopharmaceutical, biotechnology, and other life sciences research institutions. The company’s product sales are predominantly conducted through a direct sales force in North America and specific European regions. The company utilizes third-party distributors for product distribution in other areas such as Asia, certain parts of Europe, Oceania, Central America, South America, the Middle East, and Africa.

Financial Highlights (FY 2023)

Company's Business Segments

• Instruments : Chromium, Spatial.
• Consumables : Chromium, Spatial.